Cure My Disease

Don't miss your cure!

 Log in / Sign up

New proton therapy could shrink skull tumor treatment to just 5 days

NCT ID NCT05861245

Recruiting now Disease control Sponsor: Quironsalud Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This phase II trial is testing a shorter course of proton therapy for people with chordomas or chondrosarcomas at the base of the skull. Instead of many sessions, patients receive radiation in just 5 consecutive days. The goal is to see if this approach is safe, controls tumor growth, and improves quality of life. The study is currently recruiting 20 participants.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Proton therapy (radiation) given in 5 sessions
What this could lead to
If successful, this could offer a shorter, more precise radiation treatment for skull base tumors, potentially reducing side effects and improving quality of life.
What could go wrong
This is a small early-phase trial with only 20 participants, so results may not apply to everyone. The treatment still carries risks of radiation side effects, and it is not a cure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHONDROSARCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chondrosarcoma chordoma skull base chordoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHONDROSARCOMA CHORDOMA

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Centro de Protonterapia Quironsalud

    RECRUITING

    Madrid, Madrid, 28223, Spain

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.